The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
T. E. Hutson
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
Honoraria - AVEO; GlaxoSmithKline; Novartis; Pfizer
Research Funding - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
R. M. Bukowski
Consultant or Advisory Role - Argos Therapeutics; Genentech; GlaxoSmithKline; Novartis; Vicus Therapeutics
Honoraria - Novartis; Pfizer; Roche/Genentech
B. I. Rini
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
M. E. Gore
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
Honoraria - AVEO; GlaxoSmithKline; Novartis; Pfizer
J. M. G. Larkin
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
R. A. Figlin
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
C. H. Barrios
Consultant or Advisory Role - Pfizer
B. Escudier
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
X. Lin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
K. D. Fly
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer (B)
B. Martell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Other Remuneration - Pfizer
E. Matczak
No relevant relationships to disclose
R. J. Motzer
Research Funding - Pfizer